India could agree to purchase high-end U.S. vehicles and military aircraft in addition to stepping up nuclear energy ...
The FDA made strides in R/R T-cell lymphoma and breast cancer. An AI tool aids pathologists and other positive updates in gastric cancer and NSCLC.
Vast has started testing a qualification model of its first commercial space station but has pushed back the launch of that ...
LONDON/SAN FRANCISCO (Reuters) - Novo Nordisk (NYSE: NVO) is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema amid a lack of clarity over ...
Aardvark Therapeutics plans a $100M IPO for metabolic treatments, targeting rare Prader-Willi syndrome with a potential ...
Barclays (LON:BARC) analyst Lauren Lieberman maintained an Underweight rating on Clorox stock (NYSE:CLX), with a price target of $130.00. According to InvestingPro data, the stock is currently trading ...
Victoria’s Secret has been upgraded to Overweight from Equal Weight by Barclays (LON: BARC), with analysts noting key ...
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves ...
Hosted on MSN19d
Ultragenyx's SWOT analysis: rare disease stock poised for growthThe observation of lower extremity weakness in the Phase 1/2 trial of GTX-102 for Angelman syndrome is a concern that warrants close monitoring in Phase 3 studies. This side effect could ...
The European giants went head to head in their penultimate Champions League league phase games of the season ... levelled the scores for Barcelona to 1-1, Szczesny inexplicably came charging ...
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results